Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Gamma-aminobutyric acid
Drug ID BADD_D01002
Description The most common inhibitory neurotransmitter in the central nervous system.
Indications and Usage Not Available
Marketing Status approved; investigational
ATC Code Not Available
DrugBank ID DB02530
KEGG ID D00058
MeSH ID D005680
PubChem ID 119
TTD Drug ID D0C9XA
NDC Product Code 44911-0002
UNII 2ACZ6IPC6I
Synonyms gamma-Aminobutyric Acid | gamma Aminobutyric Acid | GABA | Aminalon | Aminalone | 4-Aminobutanoic Acid | 4 Aminobutanoic Acid | 4-Aminobutyric Acid | 4 Aminobutyric Acid | gamma-Aminobutyric Acid, Hydrochloride | Acid, Hydrochloride gamma-Aminobutyric | Hydrochloride gamma-Aminobutyric Acid | gamma Aminobutyric Acid, Hydrochloride | Gammalon | gamma-Aminobutyric Acid, Monosodium Salt | gamma Aminobutyric Acid, Monosodium Salt | gamma-Aminobutyric Acid, Zinc Salt (2:1) | gamma-Aminobutyric Acid, Calcium Salt (2:1) | gamma-Aminobutyric Acid, Monolithium Salt | gamma Aminobutyric Acid, Monolithium Salt | Lithium GABA | GABA, Lithium
Chemical Information
Molecular Formula C4H9NO2
CAS Registry Number 56-12-2
SMILES C(CC(=O)O)CN
Chemical Structure
ADRs Induced by Drug
*The priority for ADR severity classification is based on FAERS assessment, followed by the most severe level in CTCAE rating. If neither is available, it will be displayed as 'Not available'.
**The 'Not Available' level is hidden by default and can be restored by clicking on the legend twice..
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Anaphylactic shock24.06.02.004; 10.01.07.002--Not Available
Angioedema10.01.05.009; 22.04.02.008; 23.04.01.001--Not Available
Injection site pain12.07.03.011; 08.02.03.010--Not Available
Pain08.01.08.004--
Rash23.03.13.001--Not Available
Skin irritation23.03.04.009--Not Available
Urticaria10.01.06.001; 23.04.02.001--
The 1th Page    1    Total 1 Pages